Does Cimicifuga racemosa cause hepatotoxicity? A comment on the Australian case reports;Hepatotoxizität durch Cimicifuga racemosa?

Zeitschrift fur Phytotherapie

Volumn 24, Issue 1, 2003, Pages 11-14

  Thomsen, Michael ^a   Schmidt, Mathias ^b  

^a National Herbalists Association of Australia   (Australia)

^b NONE

Author keywords

Black cohosh; Cimicifuga racemosa; Hepatitis; Hepatotoxicity; Herbal drugs

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; HERBACEOUS AGENT; KAVA;

ARTICLE; AUSTRALIA; HEPATITIS; HUMAN; INGESTION; LIVER DISEASE; LIVER TOXICITY; MEDICAL LITERATURE; MEDICINAL PLANT; RESEARCH;

EID: 17044461991     PISSN: 0722348X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Awang DV: Siberian ginseng toxicity may be case of mistaken identity. Can Med Assoc J 1996; 155: 1237.
2. Boblitz N, Liske E, Wüstenberg P: Traubensilberkerze. Wirksamkeit, Wirkung und Sicherheit von Cimicifuga racemosa in der Gynäkologie. Dtsch Apoth Ztg 2000; 140: 2833-2838.
3. Corrigan D: Adverse Reports - some first principles. The European Phytojournal, Issue 2: Proceedings of the 6th International ES-COP Symposium 2001 (www.escop.com).
4. D'Arcy PF: Adverse reactions and interactions with herbal medicines. Part 1. Adverse reactions. Adverse Drug React Toxicol Rev 1991; 10: 189-208.
5. Frösner GG, Schomerus H, Wiedmann KH, et al.: Diagnostic significance of quantitative HbsAg determination in acute and chronic hepatitis B infection. Europ J Clin Microbiol 1982; 1: 52-58.
6. Fugh-Berman A: Herb-drug interactions. Lancet 2000; 355: 134-138.
7. Huxtable RJ: The myth of beneficient nature: the risks of herbal preparations. Ann Int Med 1992; 117: 165-166.
8. Laliberté L, Villeneuve JP: Hepatitis after the use of germander, a herbal remedy. Can Med Assoc J 1996; 154: 1689-1692.
9. Liebermann S: A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Women's Health 1998; 7: 525-529.
10. MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC: Hepatotoxicity of herbal remedies. BMJ 1989; 299: 1156-1157.
11. Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL: Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 2002; 17: 408-412.
12. McGuffin M, Hobbs C, Upton R, Goldberg A: American Herbal Product Association's Botanical Safety Handbook. Boca Raton, Florida: CRC Press, 1997.
13. Miskelly FG, Goodyer LI: Hepatic and pulmonary complications of herbal medicines. Postgrad Med J 1992; 68: 935.
14. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, et al.: Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342: 1686-1692.
15. Schilcher H, Heil BM: Nierentoxizität von Wacholderbeerzubereitungen. Z Phytother 1994; 15: 205-213.
16. Stedman C: Herbal hepatotoxicity. Semin Liver Dis 2002; 22: 195-206.
17. Violon C: Belgian (Chinese herb) nephropathy: why? J Pharm Belg 1997; 52: 7-27.
18. Walker AM. The occurrence of new hepatic disorders in a defined population. Post Marketing Surveillance 1992; 1: 107-111.
19. Whiting PW, Clouston A, Kerlin P: Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002; 177: 440-443.